Search
FDA Approves Bayer's Prostate Cancer Drug Nubeqa
2 week ago /
Read about 0 minute
Author：小编
Bayer AG has announced the approval of its drug Nubeqa by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of prostate cancer. This approval stems from the results of Phase 3 clinical trials, which demonstrated that Nubeqa, when used in combination therapy, can significantly reduce the risk of radiological progression or death by 46%. This development offers a promising new treatment option for patients affected by this condition.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
